Welleman Ilse M, Szymanski Wiktor
Universiteit van Groningen-UMC Groningen, Medical Imaging Center, Groningen.
Contact: Ilse M. Welleman (
Ned Tijdschr Geneeskd. 2023 Mar 13;167:D7444.
For millennia, humanity has been fascinated by the prospect of using visible light in medical applications. Nowadays, light is used in the clinic for intraoperative imaging and photodynamic therapy, among others. However, the precision of light delivery has also the potential to enable safe and targeted pharmacological treatments. This is the dream behind the emerging field of photopharmacology, which develops drugs whose activity can be regulated with light irradiation. Those photopharmacological drugs can be designed in two ways. Firstly, the drug can be "silenced" by attachment of a group that can be locally removed with light. Secondly, a molecular photoswitch can be inserted into a drug molecule to enable it switching on and off with different colours of light. In this article, a perspective is given on the basic principles and future of photopharmacology on its way to clinical applications.
数千年来,人类一直着迷于在医学应用中使用可见光的前景。如今,光在临床上用于术中成像和光动力疗法等。然而,光传递的精确性也有潜力实现安全且有针对性的药物治疗。这就是光药理学这一新兴领域背后的梦想,该领域研发出其活性可通过光照射来调节的药物。那些光药理学药物可以通过两种方式设计。首先,药物可以通过连接一个可被光局部去除的基团而“沉默”。其次,可以将分子光开关插入药物分子中,使其能通过不同颜色的光来开启和关闭。本文阐述了光药理学在迈向临床应用过程中的基本原理和未来前景。